HUMAN RHO(D) IMMUNE GLOBULIN

HUMAN RHO(D) IMMUNE GLOBULIN was reported 1027 times

HUMAN RHO(D) IMMUNE GLOBULIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI KELL ANTIBODY TEST POSITIVE 2 0.6667
1 RHESUS ANTIBODIES POSITIVE 59 0.5315
2 BLOOD INCOMPATIBILITY HAEMOLYTIC ANAEMIA OF NEWBORN 1 0.3333
3 ALLOIMMUNE HAEMOLYTIC ANAEMIA 3 0.3000
4 GESTATIONAL ALLOIMMUNE LIVER DISEASE 1 0.2500
5 PIK3CA RELATED OVERGROWTH SPECTRUM 4 0.2500
6 COOMBS INDIRECT TEST NEGATIVE 1 0.2000
7 RHESUS ANTIBODIES 4 0.1739
8 FOETAL-MATERNAL HAEMORRHAGE 8 0.1667
9 CONGENITAL HYPERINSULINAEMIC HYPOGLYCAEMIA 2 0.1667
10 ISOIMMUNE HAEMOLYTIC DISEASE 5 0.1316
11 STICKY PLATELET SYNDROME 1 0.1111
12 PANCREATIC ISLETS HYPERPLASIA 2 0.0952
13 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 39 0.0850
14 CONTAMINATED PRODUCT ADMINISTERED 5 0.0820
15 ANTIGLIADIN ANTIBODY POSITIVE 2 0.0800
16 RHESUS HAEMOLYTIC DISEASE OF NEWBORN 1 0.0769
17 MISLEADING LABORATORY TEST RESULT 6 0.0723
18 PROTEIN URINE ABSENT 1 0.0625
19 COOMBS INDIRECT TEST POSITIVE 4 0.0541
20 RHESUS INCOMPATIBILITY 6 0.0496
21 SYNOVIAL FLUID ANALYSIS 4 0.0460
22 COOMBS DIRECT TEST POSITIVE 13 0.0417
23 DIRECTIONAL DOPPLER FLOW TESTS ABNORMAL 1 0.0385
24 OEDEMA NEONATAL 2 0.0370
25 CONGENITAL LARYNGEAL STRIDOR 1 0.0345
26 LYMPHOCYTOPENIA NEONATAL 1 0.0333
27 DISSEMINATED INTRAVASCULAR COAGULATION IN NEWBORN 1 0.0323
28 CONGENITAL INFECTION 2 0.0323
29 MYCOPLASMA SEROLOGY POSITIVE 1 0.0303
30 HIGH ARCHED PALATE 5 0.0292
31 POLYMORPHIC ERUPTION OF PREGNANCY 1 0.0286
32 SPONTANEOUS RUPTURE OF MEMBRANES 1 0.0286
33 ANTI-HBC IGG ANTIBODY POSITIVE 1 0.0278
34 ANTERIOR DISPLACED ANUS 1 0.0263
35 CONGENITAL BOWING OF LONG BONES 2 0.0247
36 LARYNGOMALACIA 8 0.0239
37 FOETAL ANAEMIA 3 0.0229
38 SENSORY PROCESSING SENSITIVITY 1 0.0227
39 ALLOIMMUNISATION 1 0.0217
40 CRANIAL SUTURES WIDENING 3 0.0217
41 PROLONGED RUPTURE OF MEMBRANES 1 0.0217
42 CAFE AU LAIT SPOTS 2 0.0200
43 ERYTHROBLASTOSIS 1 0.0200
44 FOETAL VASCULAR MALPERFUSION 1 0.0196
45 APNOEA NEONATAL 5 0.0193
46 HAEMORRHAGE FOETAL 1 0.0189
47 POSTPARTUM SEPSIS 1 0.0175
48 UMBILICAL CORD SHORT 1 0.0175
49 GENITALIA EXTERNAL AMBIGUOUS 3 0.0173
50 CEREBRAL HAEMORRHAGE FOETAL 1 0.0164
51 LYMPHADENITIS 39 0.0161
52 VAGINAL HAEMATOMA 1 0.0156
53 FOETAL MALNUTRITION 2 0.0155
54 CAPILLARY PERMEABILITY INCREASED 1 0.0154
55 HAEMOLYTIC TRANSFUSION REACTION 1 0.0154
56 MECONIUM ILEUS 1 0.0152
57 SPHEROCYTIC ANAEMIA 1 0.0145
58 CEREBRAL MICROHAEMORRHAGE 6 0.0132
59 CAMPTODACTYLY CONGENITAL 1 0.0132
60 GASTROINTESTINAL TOXICITY 63 0.0131
61 ANTI-ERYTHROCYTE ANTIBODY POSITIVE 1 0.0122
62 THROMBOCYTOPENIA NEONATAL 5 0.0119
63 OBSTRUCTED LABOUR 2 0.0118
64 CONGENITAL VESICOURETERIC REFLUX 1 0.0116
65 FOETAL HEART RATE INCREASED 1 0.0114
66 MECONIUM IN AMNIOTIC FLUID 4 0.0114
67 HEPATITIS C ANTIBODY POSITIVE 3 0.0111
68 VISUOSPATIAL DEFICIT 1 0.0110
69 HYPERBILIRUBINAEMIA NEONATAL 6 0.0103
70 DEFICIENCY OF BILE SECRETION 1 0.0100
71 LEUKOERYTHROBLASTOSIS 1 0.0100
72 PERSISTENT FOETAL CIRCULATION 6 0.0098
73 MUSCLE TONE DISORDER 3 0.0096
74 PULMONARY OEDEMA NEONATAL 1 0.0096
75 BRADYCARDIA NEONATAL 12 0.0095
76 RETICULOCYTOSIS 2 0.0094
77 FOETAL MALPRESENTATION 1 0.0093
78 C-REACTIVE PROTEIN ABNORMAL 59 0.0092
79 TENOSYNOVITIS STENOSANS 5 0.0090
80 PULMONARY TOXICITY 63 0.0089
81 SYRINGE ISSUE 155 0.0088
82 SYNOVIAL DISORDER 4 0.0088
83 FOETAL HYPOKINESIA 6 0.0086
84 RIGHT VENTRICLE OUTFLOW TRACT OBSTRUCTION 1 0.0085
85 NEONATAL RESPIRATORY DISTRESS 8 0.0085
86 UTERINE MALPOSITION 1 0.0085
87 NEONATAL ASPHYXIA 6 0.0085
88 MIGRAINE WITH AURA 23 0.0085
89 KIDNEY DUPLEX 2 0.0083
90 MENINGOMYELOCELE 5 0.0083
91 UMBILICAL CORD PROLAPSE 1 0.0081
92 FORCEPS DELIVERY 1 0.0077
93 PULMONARY ARTERY STENOSIS 3 0.0077
94 CONGENITAL RENAL DISORDER 2 0.0075
95 UTERINE HYPERTONUS 2 0.0074
96 INTRAUTERINE INFECTION 1 0.0074
97 LABOUR INDUCTION 1 0.0074
98 COOMBS TEST POSITIVE 2 0.0073
99 WARM AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0071
100 NEWBORN PERSISTENT PULMONARY HYPERTENSION 2 0.0071
101 MATERNAL EXPOSURE DURING DELIVERY 7 0.0071
102 POST ABORTION HAEMORRHAGE 1 0.0070
103 HYPOTHERMIA NEONATAL 1 0.0070
104 PULMONARY VENOUS THROMBOSIS 1 0.0067
105 CONGENITAL SCOLIOSIS 1 0.0066
106 RETAINED PLACENTA OR MEMBRANES 2 0.0066
107 SHOULDER DYSTOCIA 1 0.0066
108 TRANSFUSION-RELATED ACUTE LUNG INJURY 2 0.0065
109 MALABSORPTION FROM INJECTION SITE 2 0.0065
110 AMNIOCENTESIS ABNORMAL 1 0.0064
111 PLACENTA PRAEVIA 5 0.0064
112 AMNIOTIC FLUID VOLUME INCREASED 1 0.0063
113 AGITATION NEONATAL 6 0.0063
114 HAEMOLYSIS 47 0.0061
115 PATENT DUCTUS ARTERIOSUS 24 0.0060
116 POLYDACTYLY 7 0.0060
117 NEONATAL RESPIRATORY DEPRESSION 2 0.0060
118 FOETAL MONITORING ABNORMAL 1 0.0060
119 HAND-EYE COORDINATION IMPAIRED 1 0.0059
120 CERVICAL INCOMPETENCE 3 0.0059
121 SPEECH SOUND DISORDER 1 0.0058
122 RETROPLACENTAL HAEMATOMA 1 0.0058
123 FEEDING DISORDER NEONATAL 6 0.0057
124 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 7 0.0055
125 CONGENITAL UMBILICAL HERNIA 2 0.0054
126 DEVELOPMENTAL COORDINATION DISORDER 1 0.0053
127 AMNIORRHOEA 1 0.0053
128 PYELOCALIECTASIS 5 0.0052
129 PRODUCT COUNTERFEIT 9 0.0052
130 CONGENITAL ARTERIAL MALFORMATION 1 0.0052
131 MOTOR DEVELOPMENTAL DELAY 3 0.0052
132 CONGENITAL MEGAURETER 1 0.0052
133 FAILED INDUCTION OF LABOUR 1 0.0052
134 ENCOPRESIS 1 0.0052
135 ANTIBODY TEST NEGATIVE 1 0.0051
136 VESICOURETERIC REFLUX 2 0.0049
137 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 6 0.0048
138 HYPOCAPNIA 2 0.0048
139 ANEMBRYONIC GESTATION 1 0.0048
140 CEREBRAL HAEMORRHAGE NEONATAL 1 0.0047
141 MICROCEPHALY 6 0.0047
142 GESTATIONAL DIABETES 22 0.0046
143 MEDICATION MONITORING ERROR 1 0.0046
144 DELIVERY 3 0.0046
145 NODULAR RASH 1 0.0045
146 PLACENTAL INFARCTION 1 0.0045
147 POSTPARTUM HAEMORRHAGE 6 0.0045
148 EAR MALFORMATION 2 0.0043
149 RESPIRATORY DISORDER NEONATAL 7 0.0043
150 CRANIOFACIAL DEFORMITY 1 0.0043
151 WOLFF-PARKINSON-WHITE SYNDROME 2 0.0042
152 SMALL FOR DATES BABY 21 0.0042
153 JAUNDICE NEONATAL 8 0.0042
154 BIOPSY SKIN ABNORMAL 1 0.0042
155 TRANSFUSION-RELATED CIRCULATORY OVERLOAD 1 0.0041
156 ENCEPHALOCELE 1 0.0040
157 MENINGORRHAGIA 1 0.0040
158 CYANOSIS CENTRAL 1 0.0038
159 RED BLOOD CELL SEDIMENTATION RATE DECREASED 1 0.0038
160 UTERINE ATONY 1 0.0038
161 NEONATAL DISORDER 6 0.0038
162 ANAL STENOSIS 2 0.0038
163 FOETAL ARRHYTHMIA 1 0.0037
164 INFANTILE APNOEA 3 0.0037
165 CENTRAL NERVOUS SYSTEM NECROSIS 1 0.0036
166 ANTIBODY TEST POSITIVE 6 0.0036
167 FOETAL MACROSOMIA 1 0.0036
168 PRODUCT INFORMATION CONTENT COMPLAINT 1 0.0036
169 AUTOANTIBODY POSITIVE 1 0.0036
170 TRANSMISSION OF AN INFECTIOUS AGENT VIA A MEDICINAL PRODUCT 3 0.0035
171 SUSPECTED COUNTERFEIT PRODUCT 14 0.0035
172 BURKHOLDERIA CEPACIA COMPLEX INFECTION 1 0.0035
173 REGRESSIVE BEHAVIOUR 1 0.0034
174 DYSMORPHISM 8 0.0034
175 LEFT-TO-RIGHT CARDIAC SHUNT 1 0.0034
176 TISSUE INFILTRATION 1 0.0034
177 POLYCHROMASIA 1 0.0033
178 JOINT LAXITY 1 0.0033
179 HYDROPS FOETALIS 2 0.0033
180 ATRIAL SEPTAL DEFECT 27 0.0032
181 ALLERGY TO CHEMICALS 4 0.0032
182 ANOMALY OF EXTERNAL EAR CONGENITAL 1 0.0032
183 FOETAL CARDIAC DISORDER 1 0.0032
184 RIGHT VENTRICULAR ENLARGEMENT 1 0.0031
185 CYANOSIS NEONATAL 2 0.0031
186 DOUBLE STRANDED DNA ANTIBODY POSITIVE 1 0.0031
187 INTERMENSTRUAL BLEEDING 17 0.0030
188 CENTRAL NERVOUS SYSTEM INFLAMMATION 1 0.0030
189 JOINT INJURY 64 0.0030
190 BACTERIAL PYELONEPHRITIS 1 0.0030
191 RENAL VEIN THROMBOSIS 2 0.0030
192 CONGENITAL HAND MALFORMATION 2 0.0029
193 GAIT SPASTIC 1 0.0029
194 UTERINE CONTRACTIONS DURING PREGNANCY 3 0.0029
195 TALIPES 9 0.0029
196 FIBROUS HISTIOCYTOMA 1 0.0028
197 HEPATOTOXICITY 63 0.0028
198 LYMPHOID TISSUE HYPERPLASIA 1 0.0028
199 IMMUNISATION REACTION 2 0.0028
200 WRONG PATIENT RECEIVED PRODUCT 8 0.0027
201 ECLAMPSIA 1 0.0027
202 PHIMOSIS 2 0.0027
203 ADENOIDAL HYPERTROPHY 1 0.0026
204 HYPEREMESIS GRAVIDARUM 1 0.0026
205 MACROCEPHALY 1 0.0026
206 NEONATAL RESPIRATORY DISTRESS SYNDROME 9 0.0025
207 PULMONARY HYPOPLASIA 2 0.0025
208 PULMONARY VALVE STENOSIS 2 0.0025
209 SCLERITIS 4 0.0025
210 BRAIN COMPRESSION 1 0.0025
211 SEPSIS NEONATAL 2 0.0025
212 PERIPHERAL CIRCULATORY FAILURE 1 0.0024
213 DEVELOPMENTAL HIP DYSPLASIA 2 0.0024
214 EXTRAVASCULAR HAEMOLYSIS 1 0.0024
215 THREATENED LABOUR 1 0.0023
216 TRANSFUSION REACTION 2 0.0023
217 LACK OF SPONTANEOUS SPEECH 1 0.0023
218 HEPATIC ENZYME DECREASED 1 0.0022
219 CONGENITAL FOOT MALFORMATION 1 0.0022
220 MANUFACTURING ISSUE 1 0.0022
221 PULMONARY VASCULAR DISORDER 1 0.0021
222 DRUG DISPENSED TO WRONG PATIENT 2 0.0021
223 HAEMORRHAGE IN PREGNANCY 3 0.0021
224 ANAEMIA NEONATAL 1 0.0021
225 PLAGIOCEPHALY 1 0.0020
226 MICROGNATHIA 1 0.0020
227 JOINT STIFFNESS 51 0.0019
228 FOETAL DEATH 10 0.0019
229 HYPOSPADIAS 4 0.0019
230 VENTRICULAR SEPTAL DEFECT 11 0.0019
231 NO REACTION ON PREVIOUS EXPOSURE TO DRUG 1 0.0019
232 JOINT CONTRACTURE 2 0.0019
233 DEVICE ISSUE 167 0.0019
234 EXECUTIVE DYSFUNCTION 1 0.0018
235 HYPERTROPHY 1 0.0018
236 MANUFACTURING PRODUCT SHIPPING ISSUE 1 0.0018
237 RHEUMATOID NODULE 5 0.0018
238 PLEURITIC PAIN 5 0.0018
239 TYPE III IMMUNE COMPLEX MEDIATED REACTION 1 0.0018
240 INTRAVASCULAR HAEMOLYSIS 1 0.0018
241 HAEMOGLOBINURIA 2 0.0018
242 CRYPTORCHISM 2 0.0018
243 MEDICAL DEVICE SITE PAIN 1 0.0018
244 KLEBSIELLA SEPSIS 2 0.0018
245 DYSPRAXIA 1 0.0018
246 BLOOD FIBRINOGEN DECREASED 2 0.0018
247 CEREBRAL VENTRICLE DILATATION 2 0.0017
248 LIMB REDUCTION DEFECT 1 0.0017
249 DOSE CALCULATION ERROR 1 0.0017
250 MATERNAL DRUGS AFFECTING FOETUS 13 0.0017
251 PRODUCT CONTAMINATION MICROBIAL 2 0.0017
252 FOETAL HEART RATE DECREASED 1 0.0016
253 MATERNAL EXPOSURE TIMING UNSPECIFIED 6 0.0016
254 DACRYOSTENOSIS ACQUIRED 2 0.0015
255 GESTATIONAL HYPERTENSION 2 0.0015
256 BLOOD IMMUNOGLOBULIN A DECREASED 1 0.0015
257 HIV TEST POSITIVE 1 0.0015
258 THEFT 1 0.0015
259 TENOSYNOVITIS 4 0.0014
260 DEATH NEONATAL 2 0.0014
261 HAEMORRHAGIC CEREBRAL INFARCTION 1 0.0014
262 MAST CELL ACTIVATION SYNDROME 2 0.0014
263 FALSE NEGATIVE INVESTIGATION RESULT 1 0.0014
264 FOETAL DISTRESS SYNDROME 3 0.0014
265 ALCOHOL INTOLERANCE 1 0.0014
266 ALPHA 1 FOETOPROTEIN INCREASED 1 0.0014
267 CONGENITAL HYDRONEPHROSIS 1 0.0014
268 ANTIBODY TEST ABNORMAL 1 0.0014
269 THERAPY NON-RESPONDER 62 0.0014
270 THERAPEUTIC PRODUCT EFFECT DECREASED 61 0.0014
271 CREPITATIONS 4 0.0013
272 FOETAL EXPOSURE DURING PREGNANCY 108 0.0013
273 FOETAL GROWTH RESTRICTION 8 0.0013
274 UMBILICAL HERNIA 6 0.0013
275 MATERNAL EXPOSURE DURING PREGNANCY 114 0.0013
276 TRANSCRIPTION MEDICATION ERROR 2 0.0013
277 NO ADVERSE EVENT 231 0.0013
278 EXPOSURE DURING PREGNANCY 79 0.0013
279 CUSHINGOID 4 0.0012
280 RETICULOCYTE COUNT INCREASED 1 0.0012
281 VULVOVAGINAL DRYNESS 4 0.0012
282 HYPOGLYCAEMIA NEONATAL 2 0.0012
283 ANTINUCLEAR ANTIBODY POSITIVE 4 0.0012
284 NEONATAL HYPOXIA 1 0.0012
285 SYSTEMIC INFECTION 2 0.0012
286 BRADYCARDIA FOETAL 1 0.0012
287 MUSCULOSKELETAL PAIN 63 0.0012
288 VEIN RUPTURE 2 0.0012
289 CEREBRAL VENOUS SINUS THROMBOSIS 1 0.0012
290 GINGIVAL BLEEDING 16 0.0012
291 MATERNAL EXPOSURE BEFORE PREGNANCY 8 0.0012
292 LIP PRURITUS 1 0.0012
293 CRANIOSYNOSTOSIS 1 0.0012
294 FOOD REFUSAL 1 0.0011
295 LARGE FOR DATES BABY 1 0.0011
296 CYTOMEGALOVIRUS TEST POSITIVE 2 0.0011
297 PARVOVIRUS B19 INFECTION 1 0.0011
298 ARTHROPATHY 62 0.0011
299 HYPOGLYCAEMIC SEIZURE 1 0.0011
300 SUSPECTED PRODUCT QUALITY ISSUE 2 0.0011
301 PRURIGO 1 0.0011
302 EXTENSOR PLANTAR RESPONSE 1 0.0011
303 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0011
304 CEREBRAL PALSY 1 0.0011
305 SPEECH DISORDER DEVELOPMENTAL 3 0.0010
306 FALSE POSITIVE INVESTIGATION RESULT 1 0.0010
307 SUSPECTED PRODUCT CONTAMINATION 1 0.0010
308 POLYHYDRAMNIOS 1 0.0010
309 NEOPLASM MALIGNANT 64 0.0010
310 TREATMENT FAILURE 79 0.0010
311 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 1 0.0009
312 PILOERECTION 1 0.0009
313 PREMATURE DELIVERY 14 0.0009
314 DRUG WITHDRAWAL SYNDROME NEONATAL 13 0.0009
315 SYNOVIAL CYST 4 0.0009
316 HAEMANGIOMA 2 0.0009
317 EXTRASYSTOLES 6 0.0009
318 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 61 0.0009
319 HYPORESPONSIVE TO STIMULI 1 0.0009
320 FOETAL ANTICONVULSANT SYNDROME 1 0.0008
321 SKIN WEEPING 3 0.0008
322 GANGRENE 5 0.0008
323 STILLBIRTH 4 0.0008
324 CONTRAINDICATED PRODUCT ADMINISTERED 25 0.0008
325 FEBRILE CONVULSION 1 0.0008
326 CARDIAC MURMUR 7 0.0008
327 POST-ACUTE COVID-19 SYNDROME 1 0.0008
328 BLOOD UREA DECREASED 1 0.0008
329 NASAL PRURITUS 1 0.0008
330 BREECH PRESENTATION 1 0.0008
331 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0008
332 TRISOMY 21 1 0.0008
333 APGAR SCORE LOW 1 0.0008
334 DRUG CLEARANCE DECREASED 1 0.0008
335 LOW BIRTH WEIGHT BABY 6 0.0008
336 MUSCULOSKELETAL STIFFNESS 65 0.0007
337 STENOTROPHOMONAS INFECTION 1 0.0007
338 PREMATURE BABY 22 0.0007
339 JOINT EFFUSION 5 0.0007
340 ENCEPHALITIS 5 0.0007
341 VIRAEMIA 1 0.0007
342 PELVIC VENOUS THROMBOSIS 1 0.0007
343 PRODUCT MONITORING ERROR 1 0.0007
344 CAESAREAN SECTION 8 0.0007
345 GROWTH RETARDATION 2 0.0007
346 GASTRITIS HAEMORRHAGIC 1 0.0007
347 BLOOD PRESSURE IMMEASURABLE 1 0.0007
348 PREMATURE SEPARATION OF PLACENTA 1 0.0006
349 HYPOTONIA NEONATAL 1 0.0006
350 DRUG INTOLERANCE 61 0.0006
351 PRE-ECLAMPSIA 3 0.0006
352 LIMB DEFORMITY 1 0.0006
353 INTRA-UTERINE DEATH 1 0.0006
354 POSTURE ABNORMAL 2 0.0006
355 INJECTION SITE ATROPHY 1 0.0006
356 SEBORRHOEIC DERMATITIS 1 0.0006
357 INFUSION RELATED REACTION 40 0.0006
358 VENA CAVA THROMBOSIS 1 0.0006
359 TROPONIN I INCREASED 1 0.0006
360 OLIGOHYDRAMNIOS 2 0.0006
361 ECTOPIC PREGNANCY WITH CONTRACEPTIVE DEVICE 1 0.0006
362 PSEUDOMONAS INFECTION 5 0.0006
363 PRODUCT CONTAINER SEAL ISSUE 1 0.0006
364 HEPATIC ENZYME INCREASED 39 0.0006
365 EXPIRED PRODUCT ADMINISTERED 19 0.0006
366 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 1 0.0006
367 WRONG DRUG ADMINISTERED 5 0.0006
368 TUNNEL VISION 1 0.0005
369 FLANK PAIN 5 0.0005
370 HYPERCOAGULATION 1 0.0005
371 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
372 INFLAMMATION 27 0.0005
373 JOINT SWELLING 63 0.0005
374 RHEUMATIC DISORDER 1 0.0005
375 DIPLEGIA 1 0.0005
376 EXPOSURE VIA BREAST MILK 2 0.0005
377 ABORTION SPONTANEOUS 20 0.0005
378 HYPERBILIRUBINAEMIA 5 0.0005
379 ANAEMIA MACROCYTIC 1 0.0005
380 EXOPHTHALMOS 1 0.0005
381 LANGUAGE DISORDER 1 0.0005
382 INFECTION 66 0.0005
383 HAEMOLYTIC ANAEMIA 4 0.0004
384 WRONG PRODUCT ADMINISTERED 3 0.0004
385 GASTROINTESTINAL HYPOMOTILITY 1 0.0004
386 HAEMOGLOBIN INCREASED 2 0.0004
387 EYELID DISORDER 1 0.0004
388 NEUROLOGICAL DECOMPENSATION 1 0.0004
389 METHAEMOGLOBINAEMIA 1 0.0004
390 DEFORMITY 4 0.0004
391 BILIRUBIN CONJUGATED INCREASED 1 0.0004
392 YELLOW SKIN 2 0.0004
393 PREMATURE RUPTURE OF MEMBRANES 1 0.0004
394 HEPATITIS C 5 0.0004
395 ATELECTASIS 4 0.0004
396 EXPIRED DRUG ADMINISTERED 2 0.0004
397 INTRAVENTRICULAR HAEMORRHAGE 1 0.0004
398 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
399 BODY TEMPERATURE INCREASED 8 0.0004
400 PERIORBITAL OEDEMA 2 0.0004
401 TENDERNESS 4 0.0004
402 FOLLICULITIS 4 0.0004
403 HAND DEFORMITY 5 0.0004
404 MIGRAINE 36 0.0004
405 NASAL DISORDER 1 0.0004
406 JOINT RANGE OF MOTION DECREASED 5 0.0004
407 OVERWEIGHT 2 0.0004
408 PHOTOPHOBIA 7 0.0004
409 BLOOD BILIRUBIN INCREASED 10 0.0004
410 TACHYPNOEA 5 0.0004
411 AUTISM SPECTRUM DISORDER 2 0.0004
412 RASH MACULO-PAPULAR 8 0.0004
413 SERUM SICKNESS 1 0.0004
414 LIVE BIRTH 3 0.0004
415 REBOUND EFFECT 4 0.0004
416 CEREBRAL THROMBOSIS 1 0.0004
417 NEUROLOGICAL SYMPTOM 2 0.0003
418 LIP PAIN 1 0.0003
419 COMA SCALE ABNORMAL 1 0.0003
420 ABORTION 1 0.0003
421 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
422 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
423 JAUNDICE 9 0.0003
424 ATYPICAL PNEUMONIA 1 0.0003
425 BURSITIS 4 0.0003
426 INGUINAL HERNIA 2 0.0003
427 EPSTEIN-BARR VIRUS INFECTION 2 0.0003
428 INJECTION SITE HYPERSENSITIVITY 1 0.0003
429 BLOOD CREATININE DECREASED 1 0.0003
430 ABORTION INDUCED 3 0.0003
431 CHILLS 37 0.0003
432 ULCER 5 0.0003
433 FACET JOINT SYNDROME 1 0.0003
434 NODULE 4 0.0003
435 INFUSION SITE HAEMORRHAGE 1 0.0003
436 PERICARDIAL EFFUSION 7 0.0003
437 QUALITY OF LIFE DECREASED 4 0.0003
438 PRODUCT ADMINISTRATION ERROR 6 0.0003
439 DIABETIC RETINOPATHY 1 0.0003
440 METRORRHAGIA 5 0.0003
441 EYE MOVEMENT DISORDER 2 0.0003
442 REGURGITATION 1 0.0003
443 NEOPLASM PROGRESSION 10 0.0003
444 PETECHIAE 3 0.0003
445 NEUTROPENIA 39 0.0003
446 DEVICE OCCLUSION 4 0.0003
447 GLOSSITIS 1 0.0003
448 ANAPHYLACTIC SHOCK 7 0.0003
449 NEURODERMATITIS 1 0.0003
450 HEPATIC NECROSIS 1 0.0003
451 DRUG EXPOSURE DURING PREGNANCY 9 0.0003
452 RHEUMATOID ARTHRITIS 30 0.0003
453 HAEMODYNAMIC INSTABILITY 2 0.0003
454 CONGENITAL ANOMALY 2 0.0003
455 WOUND SECRETION 1 0.0003
456 CYANOSIS 4 0.0003
457 VULVOVAGINAL MYCOTIC INFECTION 1 0.0003
458 PREGNANCY 5 0.0002
459 TACHYCARDIA 22 0.0002
460 ENURESIS 1 0.0002
461 EXTRAVASATION 1 0.0002
462 ANAPHYLACTOID REACTION 1 0.0002
463 MUSCLE INJURY 2 0.0002
464 CYTOMEGALOVIRUS INFECTION 4 0.0002
465 ACCIDENTAL EXPOSURE 1 0.0002
466 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
467 ANAPHYLACTIC REACTION 13 0.0002
468 PAIN IN EXTREMITY 69 0.0002
469 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
470 TENSION HEADACHE 1 0.0002
471 OCULAR ICTERUS 1 0.0002
472 CHAPPED LIPS 1 0.0002
473 MONOPLEGIA 1 0.0002
474 HEAD DISCOMFORT 4 0.0002
475 DEVICE BREAKAGE 9 0.0002
476 SUSPECTED OFF LABEL USE 1 0.0002
477 PALLOR 6 0.0002
478 C-REACTIVE PROTEIN INCREASED 8 0.0002
479 EAR DISORDER 1 0.0002
480 CONJUNCTIVITIS 4 0.0002
481 FEELING COLD 6 0.0002
482 CONDITION AGGRAVATED 65 0.0002
483 DISSEMINATED INTRAVASCULAR COAGULATION 3 0.0002
484 PRODUCT PACKAGING ISSUE 2 0.0002
485 FEELING JITTERY 4 0.0002
486 SUBCUTANEOUS ABSCESS 1 0.0002
487 FIBROMYALGIA 5 0.0002
488 PRESYNCOPE 5 0.0002
489 INFLAMMATORY MARKER INCREASED 1 0.0002
490 HAEMATOCRIT DECREASED 4 0.0002
491 ABDOMINAL TENDERNESS 1 0.0002
492 PROTEIN URINE PRESENT 1 0.0002
493 HYPOTHERMIA 2 0.0002
494 ARTHRALGIA 82 0.0002
495 OXYGEN SATURATION DECREASED 11 0.0002
496 PHLEBITIS 1 0.0002
497 EAR DISCOMFORT 2 0.0002
498 PERIPHERAL SWELLING 30 0.0002
499 HELICOBACTER INFECTION 2 0.0002
500 TONSILLITIS 1 0.0002
501 POOR QUALITY PRODUCT ADMINISTERED 2 0.0002
502 SERUM FERRITIN INCREASED 1 0.0002
503 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
504 LEARNING DISABILITY 1 0.0002
505 IMPAIRED WORK ABILITY 4 0.0002
506 BEHAVIOUR DISORDER 1 0.0002
507 NORMAL NEWBORN 1 0.0002
508 PRODUCT DISPENSING ERROR 4 0.0002
509 CONSTIPATION 40 0.0002
510 TIC 1 0.0002
511 INTESTINAL ISCHAEMIA 1 0.0002
512 RESPIRATORY DISTRESS 5 0.0002
513 PLATELET COUNT DECREASED 19 0.0002
514 PERIORBITAL SWELLING 1 0.0002
515 CIRCULATORY COLLAPSE 3 0.0002
516 MOUTH SWELLING 1 0.0002
517 POST PROCEDURAL HAEMORRHAGE 2 0.0002
518 HYPOVOLAEMIA 1 0.0002
519 HYPOXIA 6 0.0002
520 PROTHROMBIN TIME PROLONGED 1 0.0002
521 HEPATITIS B 1 0.0002
522 DRUG ADMINISTRATION ERROR 5 0.0002
523 DRUG DIVERSION 1 0.0002
524 MEDICATION ERROR 9 0.0002
525 INFUSION SITE EXTRAVASATION 1 0.0002
526 PRODUCT STORAGE ERROR 14 0.0002
527 PHOTOPSIA 1 0.0002
528 HEPATIC CYTOLYSIS 2 0.0002
529 SKIN ULCER 4 0.0002
530 INCOHERENT 1 0.0002
531 POOR QUALITY DRUG ADMINISTERED 1 0.0002
532 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1 0.0002
533 ANGINA UNSTABLE 1 0.0002
534 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
535 PRODUCT PREPARATION ISSUE 1 0.0002
536 DYSGRAPHIA 1 0.0002
537 MENINGITIS 1 0.0001
538 THROMBOSIS 12 0.0001
539 PRODUCT LABEL ISSUE 1 0.0001
540 ECCHYMOSIS 1 0.0001
541 DERMATITIS 3 0.0001
542 THROMBOCYTOPENIA 16 0.0001
543 FEAR OF INJECTION 1 0.0001
544 RED BLOOD CELL COUNT DECREASED 4 0.0001
545 VISUAL FIELD DEFECT 1 0.0001
546 SWELLING FACE 9 0.0001
547 BLINDNESS TRANSIENT 1 0.0001
548 SENSITIVE SKIN 1 0.0001
549 DUODENAL ULCER PERFORATION 1 0.0001
550 PAROSMIA 1 0.0001
551 ACIDOSIS 1 0.0001
552 PHARYNGEAL OEDEMA 2 0.0001
553 RASH PRURITIC 7 0.0001
554 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
555 APNOEA 1 0.0001
556 HAEMORRHAGIC STROKE 1 0.0001
557 BONE DENSITY DECREASED 4 0.0001
558 BLOOD ALBUMIN DECREASED 1 0.0001
559 SCIATICA 2 0.0001
560 MIOSIS 1 0.0001
561 SENSORY LOSS 1 0.0001
562 SHOCK HAEMORRHAGIC 1 0.0001
563 HYPERAESTHESIA 1 0.0001
564 ESCHERICHIA INFECTION 1 0.0001
565 ACUTE CORONARY SYNDROME 1 0.0001
566 COAGULOPATHY 2 0.0001
567 HAEMODIALYSIS 1 0.0001
568 FACE OEDEMA 2 0.0001
569 FACIAL PARALYSIS 1 0.0001
570 PRODUCT CONTAINER ISSUE 1 0.0001
571 RASH GENERALISED 3 0.0001
572 PYELONEPHRITIS 1 0.0001
573 URINE OUTPUT DECREASED 1 0.0001
574 GROIN PAIN 1 0.0001
575 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
576 PURPURA 1 0.0001
577 LYMPHADENOPATHY 4 0.0001
578 LIVER DISORDER 5 0.0001
579 RESPIRATORY RATE INCREASED 1 0.0001
580 CEREBRAL HAEMORRHAGE 4 0.0001
581 OROPHARYNGEAL DISCOMFORT 1 0.0001
582 LEUKOCYTOSIS 2 0.0001
583 SKIN LESION 3 0.0001
584 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
585 PERSONALITY CHANGE 1 0.0001
586 EYE PAIN 6 0.0001
587 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
588 CONVULSION 6 0.0001
589 CHOLESTASIS 2 0.0001
590 DRUG INEFFECTIVE 137 0.0001
591 AFFECT LABILITY 1 0.0001
592 INTERSTITIAL LUNG DISEASE 5 0.0001
593 NEEDLE ISSUE 3 0.0001
594 AUTOIMMUNE DISORDER 1 0.0001
595 HYPERSENSITIVITY 19 0.0001
596 PHARYNGEAL SWELLING 1 0.0001
597 LUNG DISORDER 5 0.0001
598 RESPIRATORY DISORDER 3 0.0001
599 HYPOTONIA 1 0.0001
600 DRY EYE 5 0.0001
601 BRAIN INJURY 1 0.0001
602 TOXIC SKIN ERUPTION 1 0.0001
603 PYREXIA 34 0.0001
604 HAEMOGLOBIN DECREASED 10 0.0001
605 INFLUENZA LIKE ILLNESS 8 0.0001
606 SWELLING 9 0.0001
607 SWOLLEN TONGUE 3 0.0001
608 PULMONARY HYPERTENSION 2 0.0001
609 INJECTION SITE DISCOMFORT 1 0.0001
610 RENAL PAIN 1 0.0001
611 BREAST PAIN 1 0.0001
612 IRRITABLE BOWEL SYNDROME 2 0.0001
613 IMPAIRED HEALING 3 0.0001
614 INJECTION SITE NODULE 1 0.0001
615 LIP SWELLING 3 0.0001
616 EYE PRURITUS 3 0.0001
617 RASH PAPULAR 2 0.0001
618 FISTULA 1 0.0001
619 BLOOD CALCIUM DECREASED 1 0.0001
620 IMPAIRED DRIVING ABILITY 1 0.0001
621 DERMATITIS CONTACT 1 0.0001
622 HAEMORRHAGE 9 0.0001
623 WHEEZING 5 0.0001
624 OCULAR HYPERAEMIA 4 0.0001
625 MUSCLE SPASTICITY 1 0.0001
626 CARDIOMEGALY 1 0.0001
627 INJECTION SITE EXTRAVASATION 1 0.0001
628 HYPERCALCAEMIA 1 0.0001
629 NAUSEA 64 0.0001
630 GENERALISED OEDEMA 1 0.0001
631 HEART RATE INCREASED 8 0.0001
632 HYPOTENSION 16 0.0001
633 DERMATITIS ALLERGIC 1 0.0001
634 BRAIN OEDEMA 1 0.0001
635 CARDIOVASCULAR DISORDER 2 0.0001
636 TREMOR 13 0.0001
637 CHEST DISCOMFORT 8 0.0001
638 GENITAL HAEMORRHAGE 1 0.0001
639 INFUSION SITE PAIN 1 0.0001
640 ARTHRITIS 6 0.0001
641 INCORRECT PRODUCT STORAGE 1 0.0001
642 BEDRIDDEN 1 0.0001
643 BLOOD PRESSURE DECREASED 5 0.0001
644 DRY MOUTH 6 0.0001
645 THROAT TIGHTNESS 2 0.0001
646 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
647 VISUAL IMPAIRMENT 9 0.0001
648 COORDINATION ABNORMAL 1 0.0001
649 APHONIA 1 0.0001
650 NECK PAIN 4 0.0001
651 LYMPHOPENIA 1 0.0001
652 SINUS TACHYCARDIA 1 0.0001
653 ANGINA PECTORIS 2 0.0001
654 EYE IRRITATION 4 0.0001
655 ACCIDENTAL UNDERDOSE 1 0.0001
656 PARAESTHESIA ORAL 1 0.0001
657 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
658 ANGIOEDEMA 3 0.0001
659 HYPOAESTHESIA ORAL 1 0.0001
660 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
661 URTICARIA 11 0.0001
662 INJECTION SITE RASH 2 0.0001
663 EMOTIONAL DISORDER 2 0.0001
664 MYALGIA 11 0.0001
665 LIMB DISCOMFORT 2 0.0001
666 RASH 28 0.0001
667 BRAIN FOG 1 0.0001
668 PNEUMOTHORAX 1 0.0001
669 DIZZINESS 31 0.0001
670 NIGHT SWEATS 2 0.0001
671 HYPOGLYCAEMIA 3 0.0001
672 MUSCLE TIGHTNESS 1 0.0001
673 BACK PAIN 14 0.0001
674 VIRAL INFECTION 2 0.0001
675 SYNCOPE 6 0.0001
676 PERICARDITIS 1 0.0001
677 DYSPNOEA 33 0.0001
678 MUSCULOSKELETAL DISCOMFORT 1 0.0001
679 DEVICE DEFECTIVE 1 0.0001
680 DELIRIUM 2 0.0001
681 PRURITUS 22 0.0001
682 RASH MACULAR 2 0.0001
683 COLD SWEAT 1 0.0001
684 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
685 THIRST 1 0.0001
686 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
687 DISTURBANCE IN ATTENTION 3 0.0001
688 WHITE BLOOD CELL COUNT DECREASED 6 0.0001
689 PELVIC PAIN 1 0.0001
690 HEPATIC CIRRHOSIS 1 0.0001
691 MUSCULAR WEAKNESS 6 0.0001
692 MALAISE 23 0.0001
693 ANAEMIA 10 0.0001
694 INJECTION SITE SWELLING 4 0.0001
695 LETHARGY 3 0.0001
696 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
697 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
698 CHOKING 1 0.0001
699 FEELING HOT 3 0.0000
700 INJECTION SITE ERYTHEMA 6 0.0000
701 ROAD TRAFFIC ACCIDENT 2 0.0000
702 MOUTH ULCERATION 1 0.0000
703 EATING DISORDER 1 0.0000
704 RETCHING 1 0.0000
705 LOSS OF CONSCIOUSNESS 6 0.0000
706 HYPOAESTHESIA 7 0.0000
707 POOR QUALITY SLEEP 1 0.0000
708 PRURITUS GENERALISED 1 0.0000
709 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
710 FAECES DISCOLOURED 1 0.0000
711 VAGINAL HAEMORRHAGE 2 0.0000
712 INJECTION SITE PRURITUS 3 0.0000
713 GLOSSODYNIA 1 0.0000
714 GASTROINTESTINAL DISORDER 4 0.0000
715 PARAESTHESIA 7 0.0000
716 CHROMATURIA 1 0.0000
717 HEART RATE IRREGULAR 1 0.0000
718 ERYTHEMA 9 0.0000
719 TINNITUS 2 0.0000
720 SHOCK 1 0.0000
721 COGNITIVE DISORDER 2 0.0000
722 PALPITATIONS 5 0.0000
723 DEVICE MALFUNCTION 3 0.0000
724 ASTHENIA 16 0.0000
725 SLEEP DISORDER 3 0.0000
726 OFF LABEL USE 37 0.0000
727 PULMONARY EMBOLISM 4 0.0000
728 PRODUCT PRESCRIBING ERROR 1 0.0000
729 RASH ERYTHEMATOUS 2 0.0000
730 OEDEMA PERIPHERAL 5 0.0000
731 ABDOMINAL PAIN LOWER 1 0.0000
732 HAEMATEMESIS 1 0.0000
733 FLUSHING 4 0.0000
734 HYPOPHAGIA 1 0.0000
735 SINUSITIS 4 0.0000
736 UNRESPONSIVE TO STIMULI 1 0.0000
737 ABDOMINAL PAIN 9 0.0000
738 DIPLOPIA 1 0.0000
739 DEAFNESS 1 0.0000
740 ECZEMA 2 0.0000
741 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
742 CHEST PAIN 7 0.0000
743 DRY SKIN 5 0.0000
744 MENSTRUATION IRREGULAR 1 0.0000
745 PAIN OF SKIN 1 0.0000
746 LIMB INJURY 1 0.0000
747 HAEMOPTYSIS 1 0.0000
748 BLISTER 2 0.0000
749 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
750 DYSSTASIA 1 0.0000
751 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
752 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
753 ASCITES 1 0.0000
754 LABORATORY TEST ABNORMAL 1 0.0000
755 URINARY INCONTINENCE 1 0.0000
756 FEELING ABNORMAL 8 0.0000
757 HEPATIC FAILURE 1 0.0000
758 CORONARY ARTERY DISEASE 1 0.0000
759 STOMATITIS 2 0.0000
760 ILL-DEFINED DISORDER 2 0.0000
761 PLEURAL EFFUSION 2 0.0000
762 VERTIGO 2 0.0000
763 DISCOMFORT 2 0.0000
764 EPILEPSY 1 0.0000
765 INJECTION SITE PAIN 10 0.0000
766 NERVOUS SYSTEM DISORDER 1 0.0000
767 VOMITING 15 0.0000
768 HEADACHE 20 0.0000
769 DRUG-INDUCED LIVER INJURY 1 0.0000
770 HEAD INJURY 1 0.0000
771 GAIT DISTURBANCE 6 0.0000
772 HYPERHIDROSIS 4 0.0000
773 RHINORRHOEA 2 0.0000
774 PRODUCT DOSE OMISSION 2 0.0000
775 STAPHYLOCOCCAL INFECTION 1 0.0000
776 TYPE 2 DIABETES MELLITUS 1 0.0000
777 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
778 ANGER 1 0.0000
779 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
780 BURNING SENSATION 2 0.0000
781 FATIGUE 22 0.0000
782 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
783 PAIN 17 0.0000
784 DRUG EFFECT INCOMPLETE 1 0.0000
785 PANIC ATTACK 1 0.0000
786 RESTLESSNESS 1 0.0000
787 SEPSIS 3 0.0000
788 DYSARTHRIA 1 0.0000
789 INCORRECT DOSE ADMINISTERED 6 0.0000
790 BLOOD PRESSURE INCREASED 4 0.0000
791 SEIZURE 3 0.0000
792 ABNORMAL BEHAVIOUR 1 0.0000
793 DISORIENTATION 1 0.0000
794 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
795 DYSKINESIA 1 0.0000
796 CARDIAC ARREST 2 0.0000
797 CARDIO-RESPIRATORY ARREST 1 0.0000
798 HYPERTENSION 5 0.0000
799 RENAL FAILURE ACUTE 1 0.0000
800 BALANCE DISORDER 2 0.0000
801 DEVICE LEAKAGE 1 0.0000
802 SEPTIC SHOCK 1 0.0000
803 MENTAL DISORDER 1 0.0000
804 ADVERSE DRUG REACTION 2 0.0000
805 VISION BLURRED 3 0.0000
806 SKIN IRRITATION 1 0.0000
807 SKIN DISCOLOURATION 1 0.0000
808 ADVERSE EVENT 2 0.0000
809 COUGH 6 0.0000
810 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
811 AGGRESSION 1 0.0000
812 SOMNOLENCE 4 0.0000
813 ABDOMINAL DISTENSION 2 0.0000
814 NERVOUSNESS 1 0.0000
815 SPEECH DISORDER 1 0.0000
816 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
817 DIARRHOEA 12 0.0000
818 OVERDOSE 4 0.0000
819 PNEUMONIA 6 0.0000
820 HYPONATRAEMIA 1 0.0000
821 ASTHMA 2 0.0000
822 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
823 DYSPHONIA 1 0.0000
824 BONE PAIN 1 0.0000
825 NASAL CONGESTION 1 0.0000
826 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
827 IRRITABILITY 1 0.0000
828 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
829 AMNESIA 1 0.0000
830 PSORIASIS 2 0.0000
831 RENAL FAILURE 2 0.0000
832 PRODUCT QUALITY ISSUE 2 0.0000
833 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
834 ABDOMINAL PAIN UPPER 3 0.0000
835 INJECTION SITE REACTION 1 0.0000
836 UNDERDOSE 1 0.0000
837 AGITATION 1 0.0000
838 BRONCHITIS 1 0.0000
839 DYSGEUSIA 1 0.0000
840 UNEVALUABLE EVENT 1 0.0000
841 ACNE 1 0.0000
842 INJECTION SITE BRUISING 1 0.0000
843 CONFUSIONAL STATE 2 0.0000
844 PRODUCT USE IN UNAPPROVED INDICATION 3 0.0000
845 RENAL IMPAIRMENT 1 0.0000
846 MYOCARDIAL INFARCTION 2 0.0000
847 NASOPHARYNGITIS 2 0.0000
848 OROPHARYNGEAL PAIN 1 0.0000
849 PRODUCT USE ISSUE 2 0.0000
850 WEIGHT INCREASED 2 0.0000
851 EMOTIONAL DISTRESS 1 0.0000
852 INSOMNIA 2 0.0000
853 DEHYDRATION 1 0.0000
854 MEMORY IMPAIRMENT 1 0.0000
855 WEIGHT DECREASED 2 0.0000
856 ANXIETY 2 0.0000
857 HOSPITALISATION 1 0.0000
858 COVID-19 1 0.0000
859 MUSCLE SPASMS 1 0.0000
860 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
861 DECREASED APPETITE 1 0.0000
862 FALL 1 0.0000
863 DEATH 2 0.0000